In addition to TPM, the alterations that may result in TERT re-expression and telomerase activation in thyroid cancer cells include genomic amplification as well as structural alterations at the TERT locus, chromatin remodeling, or hypermethylation events upstream of the TERT transcriptional start site [15]. The gene discussed is TERT; the disease is thyroid cancer.